Video

Dr. Cheah on Treatment for Nodular Lymphocyte Predominant Hodgkin Lymphoma

Author(s):

Chan Cheah, MD, University of Western Australia, discusses treatment for patients with nodular lymphocyte predominant Hodgkin lymphoma.

Chan Cheah, MD, University of Western Australia, discusses treatment for patients with nodular lymphocyte predominant Hodgkin lymphoma.

Nodular lymphocyte predominant Hodgkin lymphoma is a rare subtype of Hodgkin lymphoma, Cheah states. This rare subtype has a tendency towards late relapse.

Previously nodular lymphocyte predominant Hodgkin lymphoma was treated with the same chemotherapy regimens as Hodgkin lymphoma. However, due to the biological differences superior outcomes might be achieved by using a non-Hodgkin lymphoma protocol, explains Cheah.

<<<

More from the International Conference on Malignant Lymphoma

Related Videos
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec
Francine Foss, MD
David C. Fisher, MD
Farrukh Awan, MD
Minoo Battiwalla, MD, MS